Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment for Migraine and Mood (TEAM-M): A Randomized Controlled Trial of a Mindfulness-based Training Program

NCT05576467 is registered in ClinicalTrials.gov with Amanda Shallcross as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05576467 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment for Migraine and Mood (TEAM-M): A Randomized Controlled Trial of a Mindfulness-based Training Program
Lead sponsor
Amanda Shallcross
Phase
Not applicable
Overall status
Active, not recruiting
Start date
March 17, 2024
Completion date
October 20, 2026
Enrollment
145 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

depressive symptoms, migraine